Sonoma Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated August 8, 2017, reports the issuance of a press release regarding financial results for the fiscal quarter ended June 30, 2017. The registrant is Sonoma Pharmaceuticals, Inc., a Delaware corporation.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves as a notification that results for the quarter ended June 30, 2017, have been announced.
Guidance, Outlook, and Risks
The report contains forward-looking statements regarding the Company's intentions, beliefs, expectations, and strategies. Management notes that actual outcomes may differ materially due to risks and uncertainties discussed in the Company's Annual Report on Form 10-K. The Company does not undertake an obligation to update these statements except as required by law.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended June 30, 2017.
- Consult the most recent Form 10-K for detailed risk factors and historical financial comparisons.
- Verify the status of any forward-looking statements made in the press release against current market conditions.